Caplin Point Laboratories (BOM:524742) Change In Receivables : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories Change In Receivables?

Caplin Point Laboratories's change in receivables for the quarter that ended in Mar. 2024 was ₹0 Mil. It means Caplin Point Laboratories's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Caplin Point Laboratories's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-1,487 Mil. It means Caplin Point Laboratories's Accounts Receivable increased by ₹1,487 Mil from Mar. 2023 to Mar. 2024 .

Caplin Point Laboratories's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹5,427 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Caplin Point Laboratories's Days Sales Outstanding for the three months ended in Mar. 2024 was 109.27.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Caplin Point Laboratories's liquidation value for the three months ended in Mar. 2024 was ₹10,743 Mil.

Caplin Point Laboratories Change In Receivables Historical Data

The historical data trend for Caplin Point Laboratories's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Change In Receivables Chart

Caplin Point Laboratories Annual Data

Trend

Jun15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

-2,167.13

-504.00

-407.00

-770.10

-1,486.60

Caplin Point Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Caplin Point Laboratories Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Caplin Point Laboratories (BOM:524742) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Caplin Point Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	5427.2	/	4532.2	*	91
=	109.27

2. In Ben Graham's calculation of liquidation value, Caplin Point Laboratories's accounts receivable are only considered to be worth 75% of book value:

Caplin Point Laboratories's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	8362.6	-	3505.6	+	0.75 * 5427.2	+	0.5 * 3630.4
=	10,743

Caplin Point Laboratories Change In Receivables Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Caplin Point Laboratories (BOM:524742) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » Change In Receivables

Traded in Other Exchanges

CAPLIPOINT:India

Address

Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096

Website

https://www.caplinpoint.net

Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines